Descovy
USPSTF Gives ‘A’ Rating to All 3 Approved PrEP Medications, but Access Challenges Remain
In addition to Truvada, the new recommendations also include the daily oral drug Descovy and the long-acting ...
SEPTEMBER 6, 2023
FDA Grants New Indication for Descovy for PrEP
Descovy for PrEP is indicated to reduce the risk for sexually acquired HIV-1 infection in adults and adolescents ...
OCTOBER 3, 2019
Good Virologic Response Seen for Bictegravir in HIV
News from CROI 2017: Gilead's novel, investigational drug appears to be promising in rapidly suppressing HIV.
FEBRUARY 15, 2017
Load more